July 23, 2026- Thermo Fisher Scientific Inc. reported its financial results for the second quarter ended June 27, 2026.
Second Quarter Highlights
- Second quarter revenue grew 10% to $11.99 billion
- Second quarter GAAP diluted earnings per share (EPS) grew 9% to $4.68
- Second quarter adjusted EPS grew 13% to $6.03
“We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strategy, our team’s excellent execution and the power of our PPI Business System,” said Marc N. Casper, chairman and chief executive officer of Thermo Fisher Scientific. “Our end markets continue to strengthen and we’re making great progress enhancing our capabilities, and further advancing our trusted partner status with customers, leading to continued share gain.”